NDRG2 Expression in Colorectal Cancer
Author Information
Author(s): Lorentzen Anders, Vogel Lotte K, Lewinsky Rikke H, Sæbø Mona, Skjelbred Camilla F, Godiksen Sine, Hoff Geir, Tveit Kjell M, Lothe Inger Marie Bowitz, Ikdahl Tone, Kure Elin H, Mitchelmore Cathy
Primary Institution: Roskilde University
Hypothesis
The study aims to determine whether and at which stages NDRG2 down-regulation occurs during colonic carcinogenesis.
Conclusion
NDRG2 expression is down-regulated at a late stage during colorectal carcinogenesis.
Supporting Evidence
- NDRG2 mRNA levels were lower in colorectal carcinomas compared to normal tissue.
- NDRG2 expression levels were significantly reduced in high-risk adenomas and colorectal carcinomas.
- There was a trend for NDRG2 levels to decrease with increasing Dukes' stage.
Takeaway
This study found that a gene called NDRG2 is less active in people with colorectal cancer compared to healthy individuals, which might be important for understanding how cancer develops.
Methodology
Quantitative RT-PCR was used to measure NDRG2 mRNA levels in tissue samples from patients with colorectal adenomas and carcinomas.
Participant Demographics
The study included 20,780 individuals aged 50-64, with a mix of urban and rural populations.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website